We are live on ! Find out more
AGTC

Applied Genetic Technologies Corporation

Delisted

AGTC was delisted on the 30th of November, 2022.

52 hedge funds and large institutions have $37.9M invested in Applied Genetic Technologies Corporation in 2019 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 15 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

11% more capital invested

Capital invested by funds: $34.1M → $37.9M (+$3.77M)

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

5% less funds holding

Funds holding: 5552 (-3)

20% less repeat investments, than reductions

Existing positions increased: 12 | Existing positions reduced: 15

30% less first-time investments, than exits

New positions opened: 7 | Existing positions closed: 10

Holders
52
Holders Change
-3
Holders Change %
-5.45%
% of All Funds
1.02%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.02%
New
7
Increased
12
Reduced
15
Closed
10
Calls
$264K
Puts
Net Calls
+$264K
Net Calls Change
-$60K
Name Holding Trade Value Shares
Change
Change in
Stake
BFM
26
Boothbay Fund Management
New York
$183K
Deutsche Bank
27
Deutsche Bank
Germany
$146K +$13.7K +4,333 +15%
Susquehanna International Group
28
Susquehanna International Group
Pennsylvania
$144K +$100K +31,776 New
FDCDDQ
29
Federation des caisses Desjardins du Quebec
Quebec, Canada
$119K
Morgan Stanley
30
Morgan Stanley
New York
$94K -$29K -9,164 -31%
Northern Trust
31
Northern Trust
Illinois
$93K
MWNA
32
Marshall Wace North America
New York
$86K +$27.9K +8,831 +86%
California Public Employees Retirement System
33
California Public Employees Retirement System
California
$81K
AIM
34
Alambic Investment Management
California
$80K -$46.5K -14,704 -45%
Ohio Public Employees Retirement System (OPERS)
35
Ohio Public Employees Retirement System (OPERS)
Ohio
$77K +$53.6K +16,956 New
WMSA
36
Weiss Multi-Strategy Advisers
New York
$72K +$3.16K +1,000 +7%
Invesco
37
Invesco
Georgia
$66K
SEI Investments
38
SEI Investments
Pennsylvania
$50K
Bank of New York Mellon
39
Bank of New York Mellon
New York
$49K
FCMT
40
Founders Capital Management (Texas)
Texas
$23K +$4.43K +1,400 +39%
MAM
41
Meeder Asset Management
Ohio
$8K +$2.75K +870 +105%
LC
42
Lindbrook Capital
California
$7K +$4.74K +1,500 New
PAM
43
Panagora Asset Management
Massachusetts
$5K -$27.7K -8,749 -89%
TRCT
44
Tower Research Capital (TRC)
New York
$4K +$3K +950 New
UBS Group
45
UBS Group
Switzerland
$2K -$11.5K -3,625 -88%
Fidelity Investments
46
Fidelity Investments
Massachusetts
$2K
NFG
47
Next Financial Group
Texas
$2K
PCM
48
Prelude Capital Management
New York
$1K -$47 -15 -9%
CG
49
Cutler Group
California
$1K +$1.26K +400 New
BNP Paribas Financial Markets
50
BNP Paribas Financial Markets
France
$9 -$3 -1 -33%

AGTC Hedge Fund Activity: Q4 2019 in Review

52 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Applied Genetic Technologies Corporation (AGTC) for Q4 2019, worth a combined $37.9M — up 11% from $34.1M a quarter earlier.

Sellers outnumbered buyers: 10 funds closed out of AGTC and 7 opened new positions — a net loss of 3 holders — while 15 trimmed existing stakes and 12 added.

The largest buyer was Renaissance Technologies, adding an estimated $516K. The largest seller was D.E. Shaw & Co, exiting entirely with an estimated $228K sold.

  • 52 institutional investors held Applied Genetic Technologies Corporation (AGTC) as of Q4 2019, down from 55 in Q3 2019.
  • Funds reported $37.9M of Applied Genetic Technologies Corporation stock for Q4 2019, up 11% quarter-over-quarter.
  • 7 funds opened new Applied Genetic Technologies Corporation positions in Q4 2019 and 10 closed out, a net change of -3 holders.
  • The largest Applied Genetic Technologies Corporation buyer in Q4 2019 was Renaissance Technologies, an estimated $516K added.
  • The largest Applied Genetic Technologies Corporation seller in Q4 2019 was D.E. Shaw & Co, an estimated $228K sold.

Based on aggregated 13F filings for Q4 2019.